AI solves medical mystery: 18 children with rare diseases are diagnosed in Boston

In a feat that combines state-of-the-art technology and urgent medical need, an artificial intelligence model launched in April 2025 diagnosed 18 children with rare diseases at the Boston child hospital after years of inconclusive diagnosis. The AI identified 10 cases of rare neurodevelopmental diseases and 4 neuromuscular disorders, among others, offering answers that had escaped the doctors.

How did AI diagnose rare diseases that doctors did not identify?

The model, trained with thousands of genomic data and clinical symptoms, analyzed patterns that humans would hardly detect. He compared the characteristics of children with a global reference bank, pointing out mutations and extremely rare syndromes. In many cases, diseases were so unusual that they were not even in traditional medical manuals – the AI, however, managed to cross-reference information from scientific publications and international genetic banks to suggest accurate diagnoses.

Why is the diagnosis of AI for rare diseases controversial?

Despite its success, the use of AI in medical diagnoses still generates debates on privacy, algorithmic bias and legal responsibility. Critics warn that mistakes can have serious consequences, while advocates point out that in this case the AI saved lives – and that controversial technology, when well applied, can fill gaps where traditional medicine fails. The issue is especially sensitive in the area of rare diseases, where diagnostic time can take years and the emotional and financial cost is immense.

What does the diagnosis of rare AI diseases mean for the future of medicine?

The Boston case shows that AI can become an essential tool for rare diseases, where human knowledge is limited. Hospitals around the world have already studied implementing similar systems, but experts ask for careful regulation – especially in the face of risks such as those pointed out recently in a Microsoft alert on AI agents with web access. The combination of AI with sensitive medical data requires robust safety protocols.

The study, originally reported by Yahoo Canada, reinforces that artificial intelligence does not replace the physician, but can act as a powerful ally to unravel the more complex mysteries of genetic medicine.

Frequently Asked Questions about diagnosis of rare diseases with AI

Will AI replace doctors in the diagnosis of rare diseases?

No, AI acts as a support tool, offering suggestions that still need to be validated by human experts.

What are the risks of using AI in diagnoses?

The main risks include bias in training data, lack of transparency in algorithms and possible failure in atypical cases.

Is this model already available in Brazil?

There is no forecast yet, but the study paves the way for international partnerships and adaptations to the Brazilian reality.